Instil Bio, Inc.
TIL
$28.41
$2.7010.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.51M | -78.03M | -74.14M | -75.17M | -119.58M |
| Total Depreciation and Amortization | 2.15M | 3.12M | 3.61M | 3.91M | 3.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.51M | 40.23M | 27.43M | 22.32M | 61.83M |
| Change in Net Operating Assets | -14.83M | -10.81M | -12.61M | -9.58M | 976.00K |
| Cash from Operations | -49.68M | -45.50M | -55.70M | -58.52M | -52.81M |
| Capital Expenditure | -- | -- | -- | -58.00K | -5.22M |
| Sale of Property, Plant, and Equipment | 743.00K | 1.27M | 866.00K | 2.10M | 2.10M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.28M | 53.07M | 53.11M | 52.88M | 40.55M |
| Cash from Investing | 42.03M | 54.34M | 53.97M | 54.92M | 37.43M |
| Total Debt Issued | 85.60M | 85.60M | 85.60M | 0.00 | 0.00 |
| Total Debt Repaid | -82.84M | -82.84M | -82.84M | 0.00 | -587.00K |
| Issuance of Common Stock | 840.00K | 769.00K | 365.00K | 159.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.07M | -1.54M | -1.37M | -- | -- |
| Cash from Financing | 8.67M | 1.99M | 1.76M | 159.00K | -587.00K |
| Foreign Exchange rate Adjustments | 41.00K | 12.00K | -94.00K | -48.00K | -175.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.06M | 10.84M | -61.00K | -3.48M | -16.14M |